[
  {
    "date": "2023-06-30",
    "symbol": "KZIA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Kazia Therapeutics Limited",
    "entitycentralindexkey": 1075880,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entityvoluntaryfilers": "No",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "contactpersonnelname": "Karen Krumeich",
    "contactpersonnelemailaddress": "Karen.Krumeich@kaziatherapeutics.com",
    "entityaddressaddressline1": "Three International Towers Level 24, 300 Barangaroo Avenue",
    "entityaddresscityortown": "Sydney",
    "entityaddresspostalzipcode": 2000,
    "entityaddresscountry": "AU",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "countryregion": 61,
    "cityareacode": 2,
    "localphonenumber": "9472-4101",
    "entitycommonstocksharesoutstanding": 228029114,
    "entityincorporationstatecountrycode": "C3",
    "entityfilenumber": "0-29962",
    "security12btitle": "American Depositary Shares, each representing tenOrdinary Shares*",
    "tradingsymbol": "KZIA",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "false",
    "auditorname": "BDO Audit Pty Ltd",
    "auditorfirmid": 2256,
    "auditorlocation": "Sydney, Australia",
    "otherrevenue": 1000,
    "financeincome": 22000,
    "researchanddevelopmentexpense": 15564000,
    "sellinggeneralandadministrativeexpense": 8583000,
    "gainlossonremeasurementofcontingentconsideration": 3388000,
    "profitlossbeforetax": -20736000,
    "incometaxexpensecontinuingoperations": -271000,
    "profitloss": -20465000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 110000,
    "othercomprehensiveincome": 110000,
    "comprehensiveincome": -20355000,
    "profitlossattributabletoownersofparent": -20465000,
    "comprehensiveincomeattributabletoownersofparent": -20355000,
    "basicearningslosspersharefromcontinuingoperations": -0.1123,
    "dilutedearningslosspersharefromcontinuingoperations": -0.1123,
    "basicearningslosspershare": -0.1123,
    "dilutedearningslosspershare": -0.1123,
    "cashandcashequivalents": 5241000,
    "tradeandothercurrentreceivables": 3899000,
    "othercurrentassets": 1632000,
    "currentassets": 10772000,
    "noncurrentreceivables": 43000,
    "intangibleassetsotherthangoodwill": 17269000,
    "noncurrentassets": 17312000,
    "assets": 28084000,
    "tradeandothercurrentpayables": 4329000,
    "shorttermborrowings": 1796000,
    "currentprovisionsforemployeebenefits": 690000,
    "contingentconsiderationcurrent": 750000,
    "currentliabilities": 7565000,
    "deferredtaxliabilities": 2289000,
    "noncurrentprovisionsforemployeebenefits": 59000,
    "contingentconsiderationnoncurrent": 6121000,
    "noncurrentliabilities": 8469000,
    "liabilities": 16034000,
    "netassetsliabilities": 12050000,
    "issuedcapital": 97452000,
    "otherreserves": 3681000,
    "retainedearnings": -89083000,
    "equityattributabletoownersofparent": 12050000,
    "equity": 12050000,
    "shareissuerelatedcost": 401000,
    "increasedecreasethroughsharebasedpaymenttransactions": 1159000,
    "issueofequity": 13373000,
    "adjustmentsfordepreciationandamortisationexpense": 1869000,
    "adjustmentsforsharebasedpayments": 1159000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 46000,
    "considerationpaidreceived": 2097000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -19488000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 3450000,
    "adjustmentsfordecreaseincreaseinprepayments": 365000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 569000,
    "adjustmentsforprovisions": 264000,
    "adjustmentsforincreasedecreaseindeferredtaxliabilities": -271000,
    "adjustmentforincreasedecreaseinborrowingscurrent": -45000,
    "cashflowsfromusedinoperatingactivities": -15156000,
    "proceedsfromissuingshares": 12972000,
    "cashflowsfromusedinfinancingactivities": 12972000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -2184000,
    "effectofexchangeratechangesoncashandcashequivalents": 64000,
    "currentassetsliabilities": 3207572,
    "cashflowsfromusedinoperatingactivitiesnet": -15156157,
    "intangibleassetswithindefiniteremainingusefullife": "15 years",
    "netamounteligibletobeofferedforissue": 27800000,
    "percentagemilestonetriggertoaccountcostofassetconferredunderlicenseagreement": 0.5,
    "contingentconsideration": 6871000,
    "borrowingsadjustmenttointerestratebasis": 0.06,
    "miscellaneousotheroperatingincome": 1000,
    "otherincome": 1000,
    "researchanddevelopmentexpenseexcludingemployeebenefitsexpense": 5060000,
    "scientificadvisoryboardcosts": 31000,
    "postemploymentbenefitexpensedefinedbenefitplans": 2250000,
    "researchanddevelopmentemployeebenefitsexpensesuperannuation": 29000,
    "researchanddevelopmentemployeebenefitsexpensesharebasedpayments": 702000,
    "amortisation": 1084000,
    "netforeignexchangegainloss": -46000,
    "minimumoperatingleasepayment": 152000,
    "postemploymentbenefitexpensedefinedcontributionplans": 131000,
    "researchanddevelopmentexpensesexcludingamortization": 13695000,
    "totalresearchanddevelopment": 15564000,
    "generalandadministrationexpensessalarieswagesandstaffbenefits": 1467000,
    "generalandadministrationexpensessuperannuationexpenses": 102000,
    "generalandadministrationexpensessharebasedpaymentexpensesemployees": 457000,
    "generalandadministrationexpensestotalemployeebenefits": 2026000,
    "taxexpenseincomeatapplicabletaxrate": -5184000,
    "taxeffectofamortisationofintangibles": 467000,
    "taxeffectofexpenseemployeeoptionplan": 289000,
    "taxeffectofgainlossonrevaluationofcontingentconsiderationpayable": -847000,
    "taxeffectofprioryeartaxlossesnotrecognisednowrecouped": -5275000,
    "taxeffectoftaxlossesandtimingdifferencesnotrecognised": 5004000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 120412000,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 30103000,
    "applicabletaxrate": 0.25,
    "cash": 5241000,
    "currenttradereceivables": 1000,
    "otherdepositsreceivablecurrent": 3753000,
    "othercurrentreceivables": 104000,
    "amortisationintangibleassetsotherthangoodwill": 785000,
    "tradeandothercurrentpayablestotradesuppliers": 857000,
    "accrualsclassifiedascurrent": 3472000,
    "othercurrentprovisionsforemployeebenefits": 201000,
    "annualleavebenefitsprovision": 489000,
    "longserviceleave": 59000,
    "provisionsforemployeebenefits": 749000,
    "contingentconsiderationinterest": 594000,
    "impactofexchangeratesoncontingentconsideration": 697000,
    "paymentsforcontingentconsideration": 1250000,
    "milestonepaymentsnotbooked": 300500000,
    "milestonepaymentdiscountrate": 0.2,
    "numberofcontingentmilestonepayments": 4,
    "probabilityofmilestonepayments": 1,
    "percentageofdiscountrateonmilestonepayments": 0.07,
    "numberofsharesoutstanding": 228029114,
    "increasedecreaseinnumberofsharesoutstanding": 573370,
    "numberofsharesissuedandfullypaid": 228029114,
    "reserveofexchangedifferencesontranslation": -742000,
    "reserveofsharebasedpayments": 4423000,
    "financialassets": 2326000,
    "financialliabilities": 1135000,
    "riskexposureassociatedwithinstrumentssharingcharacteristicpercentagechangeinrisk": 0.1,
    "riskexposureassociatedwithinstrumentssharingcharacteristic": -494000,
    "interestrate": 0.004,
    "tradepayablesundiscountedcashflows": 857000,
    "accruedpayablesundiscountedcashflows": 3472000,
    "contingentconsiderationundiscountedcashflows": 750000,
    "nonderivativefinancialliabilitiesundiscountedcashflows": 5079000,
    "fairvalueofassetsandliabilities": 1404000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": 236000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3148000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 150000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1046000,
    "keymanagementpersonnelcompensation": 4344000,
    "auditorsremunerationforauditservices": 292000,
    "auditorsremunerationforotherservices": 18000,
    "auditorsremuneration": 310000,
    "principalplaceofbusinessofsubsidiary": "Australia",
    "countryofincorporationorresidenceofsubsidiary": "Australia",
    "proportionofownershipinterestinsubsidiary": 1,
    "lossgainonremeasurementofcontingentconsideration": 2097000,
    "adjustmentforincreasedecreaseintradeandotherpayables": 569000,
    "weightedaverageshares": 184284350,
    "adjustedweightedaverageshares": 184284350,
    "numberofantidilutiveshareoptionsexcludedfromcalculationofearningspershare": 14780000,
    "expensefromsharebasedpaymenttransactionswithemployees": 1159125,
    "percentageofoptionsvestedandexercisable": 0.75,
    "percentageofoptionsvestednotvestedandexercisable": 0.33,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P2Y11M28D",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 7930000,
    "percentageofoptionsvestedandexpectedtobevest": 0.25,
    "dateofgrantofsharebasedpaymentarrangement": "07/08/2017",
    "sharebasedpaymentarrangementoptionsexpirydate": "2022-08-07",
    "exercisepriceshareoptionsgranted2019": 0.67,
    "numberofoutstandingshareoptions": 14780000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 1550000,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 15500,
    "numberofshareoptionsexpiredsharebasedpaymentarrangement": 255500,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 6483333,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.6292,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.1785,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 1.8977,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 1.8977,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 0.9572,
    "sharepricepershare": 0.41,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.745,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0195,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.18
  },
  {
    "date": "2022-06-29",
    "symbol": "KZIA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "30 June 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Kazia Therapeutics Limited",
    "entitycentralindexkey": 1075880,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entityemerginggrowthcompany": "false",
    "entityvoluntaryfilers": "No",
    "entityshellcompany": "true",
    "entityinteractivedatacurrent": "Yes",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "contactpersonnelname": "Karen Krumeich",
    "contactpersonnelemailaddress": "Karen.Krumeich@kaziatherapeutics.com",
    "entityaddressaddressline1": "Three International Towers Level 24, 300 Barangaroo Avenue",
    "entityaddresscityortown": "Sydney",
    "entityaddresspostalzipcode": 2000,
    "entityaddresscountry": "Australia",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "countryregion": 61,
    "cityareacode": 2,
    "localphonenumber": "9472-4101",
    "entitycommonstocksharesoutstanding": 138755376,
    "entityincorporationstatecountrycode": "Australia",
    "entityfilenumber": "0-29962",
    "security12btitle": "American Depositary Shares, each representing ten Ordinary Shares*",
    "tradingsymbol": "KZIA",
    "securityexchangename": "The NASDAQ Stock Market",
    "icfrauditorattestationflag": "false",
    "auditorname": "GRANT THORNTON AUDIT PTY LTD",
    "auditorfirmid": 2233,
    "auditorlocation": "Sydney, Australia",
    "otherrevenue": 25000,
    "financeincome": 2000,
    "researchanddevelopmentexpense": 20252000,
    "sellinggeneralandadministrativeexpense": 4512000,
    "gainlossonrevaluationofcontingentconsideration": -152000,
    "commercialisation": 127000,
    "profitlossbeforetax": -25016000,
    "incometaxexpensecontinuingoperations": -368000,
    "profitloss": -23875000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 35000,
    "othercomprehensiveincome": 35000,
    "comprehensiveincome": -23875000,
    "profitlossattributabletoownersofparent": -24648000,
    "comprehensiveincomeattributabletoownersofparent": -24613000,
    "basicearningslosspersharefromcontinuingoperations": -0.1861,
    "dilutedearningslosspersharefromcontinuingoperations": -0.1861,
    "basicearningslosspershare": -0.1861,
    "dilutedearningslosspershare": -0.1861,
    "cashandcashequivalents": 7361000,
    "tradeandothercurrentreceivables": 91000,
    "othercurrentassets": 156000,
    "currentassets": 5895000,
    "noncurrentreceivables": 42000,
    "intangibleassetsotherthangoodwill": 10242000,
    "noncurrentassets": 27350000,
    "assets": 25945000,
    "tradeandothercurrentpayables": 3760000,
    "currentprovisionsforemployeebenefits": 166000,
    "contingentconsiderationcurrent": 759000,
    "currentliabilities": 1090000,
    "deferredtaxliabilities": 2560000,
    "noncurrentprovisionsforemployeebenefits": 319000,
    "contingentconsiderationnoncurrent": 1168000,
    "noncurrentliabilities": 11635000,
    "liabilities": 12407000,
    "netassetsliabilities": 18638000,
    "issuedcapital": 84480000,
    "otherreserves": 3264000,
    "retainedearnings": -74206000,
    "equityattributabletoownersofparent": 18638000,
    "equity": 13538000,
    "increasedecreasethroughothercontributionsbyowners": 4202000,
    "shareissuerelatedcost": 493000,
    "immaterialreclassificationequity": 433000,
    "increasedecreasethroughsharebasedpaymenttransactions": 1674000,
    "issueofequity": -492734,
    "increasedecreasethroughexerciseofoptions": 17000,
    "increasedecreasethroughconversionofconvertibleinstruments": -464000,
    "increasedecreasethroughexpireofoptions": 159000,
    "adjustmentsfordepreciationandamortisationexpense": 1953000,
    "adjustmentsforsharebasedpayments": 1675000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -1789000,
    "considerationpaidreceived": -152000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -22657000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -6000,
    "adjustmentsfordecreaseincreaseinprepayments": 1564000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -1495000,
    "adjustmentsforprovisions": 201000,
    "adjustmentsforincreasedecreaseindeferredtaxliabilities": -368000,
    "cashflowsfromusedinoperatingactivities": -22761000,
    "paymentofmilestonerelatingtocontingentconsiderationclassifiedasinvestingactivities": 2365000,
    "cashflowsfromusedininvestingactivities": -2365000,
    "proceedsfromissuingshares": 3726000,
    "cashflowsfromusedinfinancingactivities": 3726000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -21401000,
    "effectofexchangeratechangesoncashandcashequivalents": 1175000,
    "currentassetsliabilities": 2923084,
    "cashflowsfromusedinoperatingactivitiesnet": -22762663,
    "intangibleassetswithindefiniteremainingusefullife": "12.5 years",
    "percentagemilestonetriggertoaccountcostofassetconferredunderlicenseagreement": 0.5,
    "subsidiesandgrants": 10000,
    "baddebtrecovery": 15000,
    "otherincome": 25000,
    "researchanddevelopmentexpenseexcludingemployeebenefitsexpense": 13713000,
    "postemploymentbenefitexpensedefinedbenefitplans": 1664000,
    "researchanddevelopmentemployeebenefitsexpensesuperannuation": 25000,
    "researchanddevelopmentemployeebenefitsexpensesharebasedpayments": 365000,
    "amortisationintangibleassetsotherthangoodwill": 869000,
    "minimumoperatingleasepayment": 73000,
    "postemploymentbenefitexpensedefinedcontributionplans": 138000,
    "researchanddevelopmentexpensesexcludingamortization": 18299000,
    "totalresearchanddevelopment": 20252000,
    "generalandadministrationexpensessalarieswagesandstaffbenefits": 1674000,
    "generalandadministrationexpensessuperannuationexpenses": 129000,
    "generalandadministrationexpensessharebasedpaymentexpensesemployees": 1310000,
    "generalandadministrationexpensestotalemployeebenefits": 3113000,
    "taxexpenseincomeatapplicabletaxrate": -6254000,
    "taxeffectofamortisationofintangibles": 488000,
    "taxeffectofexpenseemployeeoptionplan": 419000,
    "taxeffectofgainlossonrevaluationofcontingentconsiderationpayable": 38000,
    "taxeffectofprioryeartaxlossesnotrecognisednowrecouped": -5309000,
    "taxeffectofadjustmentrecognisedforpriorperiods": -16000,
    "taxeffectofadjustmenttodeferredtaxbalancesasaresultofchangeinstatutorytaxrate": -113000,
    "taxeffectoftaxlossesandtimingdifferencesnotrecognised": 5038000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 2380000,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 500000,
    "applicabletaxrate": 0.21,
    "cash": 7361000,
    "othercurrentreceivables": 40000,
    "tradeandothercurrentpayablestotradesuppliers": 1524000,
    "accrualsclassifiedascurrent": 2236000,
    "accrualofemployeebenefits": 202000,
    "longserviceleave": 117000,
    "provisionsforemployeebenefits": 485000,
    "contingentconsideration": 9515000,
    "settlementofconsiderationonsatisfactionofmilestone": -2364000,
    "impactofexchangeratesoncontingentconsideration": -364000,
    "paymentsforcontingentconsideration": 1250000,
    "milestonepaymentsnotbooked": 300500000,
    "milestonepaymentdiscountrate": 0.55,
    "numberofcontingentmilestonepayments": 4,
    "numberofsharesoutstanding": 138755376,
    "increasedecreaseinnumberofsharesoutstanding": 4072660,
    "numberofsharesissuedandfullypaid": 138755376,
    "convertiblenoterepresentsordinaryshares": 1855357,
    "financialassets": 7361000,
    "financialliabilities": 3276000,
    "riskexposureassociatedwithinstrumentssharingcharacteristicpercentagechangeinrisk": -0.1,
    "riskexposureassociatedwithinstrumentssharingcharacteristic": 73611,
    "tradepayablesundiscountedcashflows": 1524000,
    "accruedpayablesundiscountedcashflows": 2236000,
    "contingentconsiderationundiscountedcashflows": 9686000,
    "nonderivativefinancialliabilitiesundiscountedcashflows": 13446000,
    "fairvalueofassetsandliabilities": 1168000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": 153000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2589000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 116000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1560000,
    "keymanagementpersonnelcompensation": 4265000,
    "auditorsremunerationforauditservices": 181000,
    "principalplaceofbusinessofsubsidiary": "Hong Kong",
    "countryofincorporationorresidenceofsubsidiary": "Hong Kong",
    "proportionofownershipinterestinsubsidiary": 1,
    "adjustmentforincreasedecreaseintradeandotherpayables": -1495000,
    "weightedaverageshares": 132467686,
    "adjustedweightedaverageshares": 132467686,
    "expensefromsharebasedpaymenttransactionswithemployees": 1674581,
    "percentageofoptionsvestedandexercisable": 0.25,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 3.048,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 100000,
    "dateofgrantofsharebasedpaymentarrangement": "24/05/2022",
    "sharebasedpaymentarrangementoptionsexpirydate": "01/02/2027",
    "exercisepriceshareoptionsgranted2019": 0.78,
    "numberofoutstandingshareoptions": 100000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 25000,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 37500,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 3180500,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 1.2826,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.611,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.67,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 1.1123,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 0.877,
    "sharepricepershare": 0.8,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.44,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.029500000000000002,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.63
  },
  {
    "date": "2021-06-30",
    "symbol": "KZIA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-06-30",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Kazia Therapeutics Limited",
    "entitycentralindexkey": 1075880,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entityvoluntaryfilers": "No",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "contactpersonnelname": "Gabrielle Heaton",
    "contactpersonnelemailaddress": "Gabrielle.Heaton@kaziatherapeutics.com",
    "entityaddressaddressline1": "Three International Towers Level 24, 300 Barangaroo Avenue",
    "entityaddresscityortown": "Sydney",
    "entityaddresspostalzipcode": 2000,
    "entityaddresscountry": "AU",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "countryregion": 61,
    "cityareacode": 2,
    "localphonenumber": "9472-4101",
    "entitycommonstocksharesoutstanding": 132012209,
    "entityincorporationstatecountrycode": "C3",
    "entityfilenumber": "0-29962",
    "security12btitle": "American Depositary Shares, each representing ten Ordinary Shares*",
    "tradingsymbol": "KZIA",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "false",
    "revenuefrominterest": 15183000,
    "otherrevenue": 2000,
    "financeincome": 42000,
    "researchanddevelopmentexpense": 14541000,
    "sellinggeneralandadministrativeexpense": 7022000,
    "gainlossonrevaluationofcontingentconsideration": -2570000,
    "profitlossbeforetax": -8906000,
    "incometaxexpensecontinuingoperations": -484000,
    "profitloss": -8422000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 2000,
    "othercomprehensiveincome": 2000,
    "comprehensiveincome": -8420000,
    "profitlossattributabletoownersofparent": -8422000,
    "comprehensiveincomeattributabletoownersofparent": -8420000,
    "basicearningslosspersharefromcontinuingoperations": -7.16,
    "dilutedearningslosspersharefromcontinuingoperations": -7.16,
    "basicearningslosspershare": -7.16,
    "dilutedearningslosspershare": -7.16,
    "cashandcashequivalents": 27587000,
    "tradeandothercurrentreceivables": 84000,
    "othercurrentassets": 1720000,
    "currentassets": 29391000,
    "noncurrentreceivables": 6694000,
    "intangibleassetsotherthangoodwill": 22003000,
    "noncurrentassets": 28697000,
    "assets": 58088000,
    "tradeandothercurrentpayables": 4933000,
    "currentprovisionsforemployeebenefits": 229000,
    "contingentconsiderationcurrent": 3165000,
    "currentliabilities": 8327000,
    "deferredtaxliabilities": 2928000,
    "noncurrentprovisionsforemployeebenefits": 55000,
    "contingentconsiderationnoncurrent": 8927000,
    "noncurrentliabilities": 11910000,
    "liabilities": 20237000,
    "netassetsliabilities": 37851000,
    "issuedcapital": 80290000,
    "otherequityinterest": 464000,
    "otherreserves": 1301000,
    "retainedearnings": -44204000,
    "equityattributabletoownersofparent": 37851000,
    "equity": 37851000,
    "increasedecreasethroughothercontributionsbyowners": 32909000,
    "shareissuerelatedcost": 1673000,
    "increasedecreasethroughsharebasedpaymenttransactions": 637000,
    "issueofequity": 273000,
    "increasedecreasethroughexpireofoptions": -323000,
    "adjustmentsfordepreciationandamortisationexpense": 1265000,
    "adjustmentsforsharebasedpayments": 637000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 430000,
    "considerationpaidreceived": -2570000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -3521000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -5027000,
    "adjustmentsfordecreaseincreaseinprepayments": -1182000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 1010000,
    "adjustmentsforprovisions": 93000,
    "adjustmentsforincreasedecreaseindeferredtaxliabilities": -484000,
    "cashflowsfromusedinoperatingactivities": -9111000,
    "proceedsfromissuingshares": 28109000,
    "cashflowsfromusedinfinancingactivities": 28109000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 18998000,
    "effectofexchangeratechangesoncashandcashequivalents": -175000,
    "currentassetsliabilities": 21064264,
    "additionaltaxdeductionpercentage": 0.435,
    "interestincomeloss": 20000000,
    "intangibleassetswithindefiniteremainingusefullife": "15 years",
    "proceedsfromnoncurrentborrowings": 25000000,
    "percentagemilestonetriggertoaccountcostofassetconferredunderlicenseagreement": 0.5,
    "numberofmajorcustomers": 2,
    "concentrationriskmajorcustomerpercentage": 0.1,
    "revenuefromcontractswithcustomers": 15183000,
    "taxrebatesonpayroll": 2000,
    "otherincome": 2000,
    "amortisationintangibleassetsotherthangoodwill": 1084000,
    "netforeignexchangeloss": 430000,
    "minimumoperatingleasepayment": 93000,
    "postemploymentbenefitexpensedefinedcontributionplans": 138000,
    "postemploymentbenefitexpensedefinedbenefitplans": 1563000,
    "chinesewithholdingtaxincurredonlicensetransaction": 931000,
    "chinesevalueaddedtaxincurredonlicensetransaction": 538000,
    "expensebynature": 1469000,
    "taxexpenseincomeatapplicabletaxrate": -2316000,
    "taxeffectofamortisationofintangibles": 348000,
    "taxeffectofexpenseemployeeoptionplan": 175000,
    "taxeffectofgainlossonrevaluationofcontingentconsiderationpayable": 707000,
    "taxeffectofprioryeartaxlossesnotrecognisednowrecouped": -1086000,
    "taxeffectofadjustmenttodeferredtaxbalancesasaresultofchangeinstatutorytaxrate": -186000,
    "taxeffectoftaxlossesandtimingdifferencesnotrecognised": 788000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 70896000,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 18433000,
    "applicabletaxrate": 0.26,
    "cash": 21087000,
    "shorttermdepositsclassifiedascashequivalents": 6500000,
    "othercurrentreceivables": 76000,
    "depositpaidnoncurrent": 6694000,
    "tradeandotherreceivables": 6778000,
    "depositpaidasadvance": 6650000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 10858000,
    "tradeandothercurrentpayablestotradesuppliers": 1893000,
    "accrualsclassifiedascurrent": 3040000,
    "provisionsforemployeebenefits": 284000,
    "contingentconsideration": 12091000,
    "paymentsforcontingentconsideration": 1250000,
    "milestonepaymentpayable": 1394000,
    "milestonepaymentsnotbooked": 300500000,
    "milestonepaymentdiscountrate": 0.15,
    "numberofcontingentmilestonepayments": 4,
    "numberofsharesoutstanding": 132012209,
    "increasedecreaseinnumberofsharesoutstanding": 25000,
    "numberofsharesissuedandfullypaid": 132012209,
    "numberofordinarysharesavailableforconversion": 1865000,
    "convertiblenoterepresentsordinaryshares": 1856000,
    "financialassets": 21073000,
    "financialliabilities": 3448000,
    "riskexposureassociatedwithinstrumentssharingcharacteristicpercentagechangeinrisk": 0.1,
    "riskexposureassociatedwithinstrumentssharingcharacteristic": -1762000,
    "interestrate": 0.0004,
    "tradepayablesundiscountedcashflows": 1893000,
    "accruedpayablesundiscountedcashflows": 3039000,
    "contingentconsiderationundiscountedcashflows": 3165000,
    "nonderivativefinancialliabilitiesundiscountedcashflows": 8097000,
    "fairvalueofassetsandliabilities": 1015000,
    "gainslossesrecognisedinprofitorlossfairvaluemeasurementassets": 2570000,
    "payoutofmilestone": -3400000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1574000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 112000,
    "keymanagementpersonnelcompensationsharebasedpayment": 617000,
    "keymanagementpersonnelcompensation": 2303000,
    "auditorsremunerationforauditservices": 151000,
    "auditorsremuneration": 151000,
    "principalplaceofbusinessofsubsidiary": "Australia",
    "countryofincorporationorresidenceofsubsidiary": "Australia",
    "proportionofownershipinterestinsubsidiary": 1,
    "adjustmentforincreasedecreaseintradeandotherpayables": 1010000,
    "weightedaverageshares": 117674543,
    "adjustedweightedaverageshares": 117674543,
    "numberofantidilutiveshareoptionsexcludedfromcalculationofearningspershare": 4446500,
    "expensefromsharebasedpaymenttransactionswithemployees": 636383,
    "percentageofoptionsvested": 0.53,
    "numberofoptionsvested": 1000000,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P2Y7M6D",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 1200000,
    "numberofoptionsissued": 1200000,
    "dateofgrantofsharebasedpaymentarrangement": "16/11/2015",
    "sharebasedpaymentarrangementoptionsexpirydate": "2021-09-05",
    "exercisepriceshareoptionsgranted2019": 2.2,
    "numberofoutstandingshareoptions": 12500,
    "numberofshareoptionsmodifiedinsharebasedpaymentarrangement": -121500,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 236667,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.826,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.09,
    "weightedaverageexercisepricemodifiedinsharebasedpaymentarrangement": 0.62,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 1.85,
    "sharepricepershare": 0.105,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.22,
    "descriptionofoptionlifeshareoptionsgranted": 1.16,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.016,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.84
  },
  {
    "date": "2020-06-30",
    "symbol": "KZIA",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-06-30",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "KAZIA THERAPEUTICS LTD",
    "entitycentralindexkey": 1075880,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityvoluntaryfilers": "No",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "contactpersonnelname": "Gabrielle Heaton",
    "entityaddressaddressline1": "Three International Towers Level 24, 300 Barangaroo Avenue",
    "entityaddresscityortown": "Sydney",
    "entityaddresspostalzipcode": 2000,
    "entityaddresscountry": "AU",
    "documentregistrationstatement": "false",
    "countryregion": 61,
    "documentaccountingstandard": "International Financial Reporting Standards",
    "cityareacode": 2,
    "entitycommonstocksharesoutstanding": 94598369,
    "localphonenumber": "9472-4101",
    "contactpersonnelemailaddress": "Gabrielle.Heaton@kaziatherapeutics.com",
    "otherrevenue": 995000,
    "financeincome": 66000,
    "researchanddevelopmentexpense": 9494000,
    "sellinggeneralandadministrativeexpense": 3690000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": -168000,
    "gainlossonrevaluationofcontingentconsideration": -474000,
    "profitlossbeforetax": -12765000,
    "incometaxexpensecontinuingoperations": -298000,
    "profitloss": -11064000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -4000,
    "othercomprehensiveincome": -4000,
    "comprehensiveincome": -11064000,
    "profitlossattributabletoownersofparent": -12467000,
    "comprehensiveincomeattributabletoownersofparent": -12471000,
    "basicearningslosspersharefromcontinuingoperations": -17.07,
    "dilutedearningslosspersharefromcontinuingoperations": -17.07,
    "basicearningslosspershare": -17.07,
    "dilutedearningslosspershare": -17.07,
    "cashandcashequivalents": 8764000,
    "tradeandothercurrentreceivables": 1352000,
    "othercurrentassets": 537000,
    "currentassets": 9703000,
    "intangibleassetsotherthangoodwill": 12410000,
    "noncurrentassets": 12410000,
    "assets": 22113000,
    "tradeandothercurrentpayables": 3489000,
    "currentprovisions": 191000,
    "contingentconsiderationcurrent": 1387000,
    "currentliabilities": 1522000,
    "deferredtaxliabilities": 3413000,
    "contingentconsiderationnoncurrent": 1845000,
    "noncurrentliabilities": 3871000,
    "liabilities": 1845000,
    "netassetsliabilities": 14125000,
    "issuedcapital": 48781000,
    "otherequityinterest": 464000,
    "otherreserves": 1521000,
    "retainedearnings": -34046000,
    "equityattributabletoownersofparent": 14125000,
    "equity": 16720000,
    "shareissuerelatedcost": 833000,
    "increasedecreasethroughsharebasedpaymenttransactions": 262000,
    "issueofequity": -833052,
    "increasedecreasethroughexpireofoptions": 1230000,
    "adjustmentsfordepreciationandamortisationexpense": 1084000,
    "adjustmentsforsharebasedpayments": 262000,
    "considerationpaidreceived": -474000,
    "gainslossesonavailableforsalefinancialassets": -168000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -10479000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 358000,
    "adjustmentsfordecreaseincreaseinprepayments": -168000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 1722000,
    "adjustmentsforprovisions": 55000,
    "adjustmentsforincreasedecreaseindeferredtaxliabilities": -298000,
    "cashflowsfromusedinoperatingactivities": -8810000,
    "proceedsfromissuingshares": 12139000,
    "cashflowsfromusedinfinancingactivities": 12139000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 3329000,
    "currentassetsliabilities": 5586128,
    "additionaltaxdeductionpercentage": 0.435,
    "interestincomeloss": 20000000,
    "intangibleassetswithindefiniteremainingusefullife": "15 years",
    "proceedsfromnoncurrentborrowings": 9000000,
    "usefullivesoramortisationratesofintangibleassetsotherthangoodwill": "5 years",
    "netforeignexchangegain": 5000,
    "taxrebatesonpayroll": 2000,
    "subsidiesandgrants": 20000,
    "rebateincomeonresearchanddevelopment": 968000,
    "otherincome": 995000,
    "amortisationintangibleassetsotherthangoodwill": 1084000,
    "depreciationandamortisationexpense": 1084000,
    "minimumoperatingleasepayment": 108000,
    "postemploymentbenefitexpensedefinedcontributionplans": 140000,
    "postemploymentbenefitexpensedefinedbenefitplans": 1526000,
    "revaluationofcontingentconsiderationexpense": 475000,
    "taxexpenseincomeatapplicabletaxrate": -3511000,
    "taxeffectofexpenseresearchanddevelopmentclaim": 280000,
    "taxeffectofexpenseemployeeoptionplan": 72000,
    "taxeffectofgainlossonrevaluationofcontingentconsiderationpayable": 131000,
    "taxeffectofexpensenotdeductibleandtaxableindeterminingtaxableprofittaxloss": -3028000,
    "taxeffectoftaxlossesandtimingdifferencesnotrecognised": 2730000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 1570000,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 330000,
    "applicabletaxrate": 0.21,
    "cash": 1264000,
    "shorttermdepositsclassifiedascashequivalents": 7500000,
    "currenttradereceivables": 1017000,
    "othercurrentreceivables": -409000,
    "guaranteedepositsassetscurrent": 250000,
    "tradeandothercurrentpayablestotradesuppliers": 1694000,
    "accrualsclassifiedascurrent": 1795000,
    "deferredtaxliabilitiescurrent1": 298000,
    "deferredtaxliabilitiesnoncurrent1": 3115000,
    "numberofcontingentmilestonepayments": 4,
    "milestonepaymentdiscountrate": 0.55,
    "paymentsforcontingentconsideration": 6044000,
    "numberofsharesoutstanding": 94598369,
    "increasedecreaseinnumberofsharesoutstanding": 19,
    "numberofsharesissuedandfullypaid": 94598369,
    "numberofordinarysharesavailableforconversion": 1865000,
    "convertiblenoterepresentsordinaryshares": 1856000,
    "financialassets": 8764000,
    "financialliabilities": 2196000,
    "riskexposureassociatedwithinstrumentssharingcharacteristicpercentagechangeinrisk": -0.1,
    "riskexposureassociatedwithinstrumentssharingcharacteristic": -245000,
    "interestrate": 0.0095,
    "nonderivativefinancialliabilitiesweightedaverageinterestrate": 82.12,
    "tradepayablesundiscountedcashflows": 1694000,
    "accruedpayablesundiscountedcashflows": 1795000,
    "contingentconsiderationundiscountedcashflows": 6843000,
    "nonderivativefinancialliabilitiesundiscountedcashflows": 10332000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1324000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 97000,
    "keymanagementpersonnelcompensationsharebasedpayment": 230000,
    "keymanagementpersonnelcompensation": 1651000,
    "auditorsremunerationforauditservices": 124000,
    "auditorsremuneration": 124000,
    "principalplaceofbusinessofsubsidiary": "Australia",
    "countryofincorporationorresidenceofsubsidiary": "Australia",
    "proportionofownershipinterestinsubsidiary": 1,
    "adjustmentforincreasedecreaseintradeandotherpayables": 1721000,
    "weightedaverageshares": 73053514,
    "adjustedweightedaverageshares": 73053514,
    "numberofantidilutiveshareoptionsexcludedfromcalculationofearningspershare": 2775167,
    "expensefromsharebasedpaymenttransactionswithemployees": 262105,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.34,
    "percentageofoptionsvested": 0.5,
    "numberofoptionsvested": 15,
    "numberofshareoptionsexpiredinsharebasedpaymentarrangement": 585599,
    "numberofshareoptionsreplacedinsharebasedpaymentarrangement": 1200000,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P2Y9M10D",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 250000,
    "percentageofoptionsvestedandexpectedtobevest": 0.5,
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "1 year",
    "descriptionofmaximumtermofoptionsgrantedforsharebasedpaymentarrangement": "5 years",
    "dateofgrantofsharebasedpaymentarrangement": "Jan. 13, 2020",
    "sharebasedpaymentarrangementoptionsexpirydate": "2024-01-04",
    "exercisepriceshareoptionsgranted2019": 0.881,
    "numberofoutstandingshareoptions": 2775167,
    "numberofshareoptionsmodifiedinsharebasedpaymentarrangement": 450000,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.797,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 0.88,
    "weightedaverageexercisepricemodifiedinsharebasedpaymentarrangement": 2.348,
    "weightedaverageexercisepriceofshareoptionsexpiredinsharebasedpaymentarrangement2019": 3.716,
    "sharepricepershare": 0.62,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.745,
    "descriptionofoptionlifeshareoptionsgranted": 4.5,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0195
  },
  {
    "date": "2019-06-30",
    "symbol": "KZIA",
    "period": "FY",
    "documenttype": "20-F",
    "contactpersonnelname": "Gabrielle Heaton",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-06-30",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "KAZIA THERAPEUTICS LTD",
    "entitycentralindexkey": 1075880,
    "currentfiscalyearenddate": "--06-30",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityvoluntaryfilers": "No",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "entityaddressaddressline1": "Three International Towers Level 24, 300 Barangaroo Avenue",
    "entityaddresscityortown": "Sydney",
    "entityaddresspostalzipcode": 2000,
    "entityaddresscountry": "AU",
    "documentregistrationstatement": "false",
    "countryregion": 61,
    "documentaccountingstandard": "International Financial Reporting Standards",
    "cityareacode": 2,
    "entitycommonstocksharesoutstanding": 62166673,
    "localphonenumber": "9472-4101",
    "contactpersonnelemailaddress": "Gabrielle.Heaton@kaziatherapeutics.com",
    "otherrevenue": 1465000,
    "financeincome": 100000,
    "researchanddevelopmentexpense": 6476000,
    "sellinggeneralandadministrativeexpense": 3786000,
    "gainslossesondisposalsofnoncurrentassets": -1000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": -1809000,
    "gainlossonrevaluationofcontingentconsideration": -63000,
    "profitlossbeforetax": -10568000,
    "incometaxexpensecontinuingoperations": -298000,
    "profitloss": -10270000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -89000,
    "othercomprehensiveincome": -89000,
    "comprehensiveincome": -10270000,
    "profitlossattributabletoownersofparent": -10270000,
    "comprehensiveincomeattributabletoownersofparent": -10359000,
    "basicearningslosspersharefromcontinuingoperations": -17.86,
    "dilutedearningslosspersharefromcontinuingoperations": -17.86,
    "basicearningslosspershare": -17.86,
    "dilutedearningslosspershare": -17.86,
    "cashandcashequivalents": 5434000,
    "tradeandothercurrentreceivables": 17000,
    "othercurrentassets": 370000,
    "currentassets": 7015000,
    "noncurrentfinancialassets": 25000,
    "intangibleassetsotherthangoodwill": 13494000,
    "noncurrentassets": 13662000,
    "assets": 1016515,
    "tradeandothercurrentpayables": 1764000,
    "currentprovisions": 136000,
    "currentliabilities": 213000,
    "deferredtaxliabilities": 3711000,
    "contingentconsiderationnoncurrent": 1370000,
    "noncurrentliabilities": 5082000,
    "liabilities": 1370000,
    "netassetsliabilities": 14195000,
    "issuedcapital": 36641000,
    "otherequityinterest": 464000,
    "otherreserves": 2489000,
    "retainedearnings": -24212000,
    "equityattributabletoownersofparent": 14195000,
    "equity": -24948000,
    "shareissuerelatedcost": 340065,
    "increasedecreasethroughsharebasedpaymenttransactions": 246000,
    "issueofequity": 3382000,
    "adjustmentsfordepreciationandamortisationexpense": 1084000,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 1000,
    "adjustmentsforsharebasedpayments": 246000,
    "considerationpaidreceived": -63000,
    "gainslossesonavailableforsalefinancialassets": -1809000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -7067000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 825000,
    "adjustmentsfordecreaseincreaseinprepayments": 398000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -409000,
    "adjustmentsforprovisions": -25000,
    "adjustmentsforincreasedecreaseindeferredtaxliabilities": -298000,
    "adjustmentsforincreasedecreaseindeferredincome": -138000,
    "cashflowsfromusedinoperatingactivities": -6714000,
    "proceedsfromsalesofinterestsinassociates": 2359000,
    "cashflowsfromusedininvestingactivities": 2359000,
    "proceedsfromissuingshares": 3816000,
    "cashflowsfromusedinfinancingactivities": 3816000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -539000,
    "effectofexchangeratechangesoncashandcashequivalents": 17000,
    "reserveofgainsandlossesonremeasuringavailableforsalefinancialassets": -36824,
    "currentassetsliabilities": 5273710,
    "additionaltaxdeductionpercentage": 0.435,
    "interestincomeloss": 20000000,
    "usefullivesordepreciationratespropertyplantandequipment": "10 years",
    "usefullivesoramortisationratesintangibleassetsotherthangoodwill": "5 years",
    "intangibleassetswithindefiniteremainingusefullife": "15 years",
    "subsidiesandgrants": 9000,
    "reimbursementofexpenses": 25000,
    "rebateincomeonresearchanddevelopment": 1431000,
    "otherincome": 8410680,
    "amortisationintangibleassetsotherthangoodwill": 1084000,
    "depreciationandamortisationexpense": 1084000,
    "minimumoperatingleasepayments": 79000,
    "postemploymentbenefitexpensedefinedcontributionplans": 128000,
    "postemploymentbenefitexpensedefinedbenefitplans": 1396000,
    "revaluationofcontingentconsiderationexpense": 63000,
    "taxexpenseincomeatapplicabletaxrate": -2906000,
    "taxeffectofexpenseresearchanddevelopmentclaim": 394000,
    "taxeffectofexpenseemployeeoptionplan": 68000,
    "taxeffectofgainlossonrevaluationofcontingentconsiderationpayable": 17000,
    "taxeffectofexpensenotdeductibleandtaxableindeterminingtaxableprofittaxloss": -2428000,
    "taxeffectoftaxlossesandtimingdifferencesnotrecognised": 2130000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 2366000,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 497000,
    "applicabletaxrate": 0.21,
    "cash": 834000,
    "shorttermdepositsclassifiedascashequivalents": 4600000,
    "currenttradereceivables": 1440000,
    "othercurrentreceivables": 564000,
    "guaranteedepositsassetscurrent": 387657,
    "impairmentlossrecognisedinprofitorlosstradereceivables": 16767,
    "disposalspropertyplantandequipment": 1000,
    "tradeandothercurrentpayablestotradesuppliers": 1050000,
    "accrualsclassifiedascurrent": 714000,
    "unusedprovisionreversedcurrentprovisions": 71000,
    "deferredtaxliabilitiescurrent1": 298000,
    "deferredtaxliabilitiesnoncurrent1": 3413000,
    "numberofcontingentmilestonepayments": 4,
    "milestonepaymentdiscountrate": 0.55,
    "paymentsforcontingentconsideration": 6843000,
    "numberofsharesoutstanding": 62166673,
    "increasedecreaseinnumberofsharesoutstanding": 8900001,
    "numberofsharesissuedandfullypaid": 62166673,
    "numberofordinarysharesavailableforconversion": 1865000,
    "convertiblenoterepresentsordinaryshares": 1856000,
    "reserveofsharebasedpayments": 2489121,
    "financialassets": 31000,
    "financialliabilities": 1047000,
    "riskexposureassociatedwithinstrumentssharingcharacteristicpercentagechangeinrisk": 0.01,
    "riskexposureassociatedwithinstrumentssharingcharacteristic": 54337,
    "interestrate": 0.0188,
    "tradepayablesundiscountedcashflows": 1049000,
    "accruedpayablesundiscountedcashflows": 714000,
    "contingentconsiderationundiscountedcashflows": 5194000,
    "nonderivativefinancialliabilitiesundiscountedcashflows": 1763000,
    "noncurrentfinancialassetsavailableforsale": 25000,
    "contingentconsiderationasset": 143000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1176000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 84000,
    "keymanagementpersonnelcompensationsharebasedpayment": 125000,
    "keymanagementpersonnelcompensation": 1385000,
    "auditorsremunerationforauditservices": 120000,
    "auditorsremuneration": 120000,
    "amountspayablerelatedpartytransactions": 165000,
    "principalplaceofbusinessofsubsidiary": "United States of America",
    "countryofincorporationorresidenceofsubsidiary": "United States of America",
    "proportionofownershipinterestinsubsidiary": 1,
    "weightedaverageshares": 57503555,
    "adjustedweightedaverageshares": 57503555,
    "numberofantidilutiveshareoptionsexcludedfromcalculationofearningspershare": 3148400,
    "expensefromsharebasedpaymenttransactionswithemployees": 246387,
    "percentageofoptionsexercisable": 0.5,
    "percentageofoptionsvested": 0.5,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions": 2.36,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 250000,
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "2 years",
    "descriptionofmaximumtermofoptionsgrantedforsharebasedpaymentarrangement": "5 years",
    "dateofgrantofsharebasedpaymentarrangement": "2019-01-04",
    "sharebasedpaymentarrangementoptionsexpirydate": "2024-01-04",
    "exercisepriceshareoptionsgranted": 0.492,
    "numberofoutstandingshareoptions": 250000,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement": 1.96,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement": 0.49,
    "sharepricepershare": 0.34,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.745,
    "descriptionofoptionlifeshareoptionsgranted": 3,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0195,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 0.14,
    "valueofsettlementoflegalproceedings": 1770000,
    "numberofunlistedoptions": 3000000,
    "unlistedoptionsexerciseprice": 0.8,
    "extinguishmentofconvertiblenotes": 136000,
    "changesinequity": 136000
  }
]